Metropolitan Life Insurance Company (MetLife)’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,125
| Closed | -$51.3K | – | 1726 |
|
|
2024
Q1 | $51.3K | Hold |
5,125
| – | – | ﹤0.01% | 1394 |
|
|
2023
Q4 | $20.9K | Hold |
5,125
| – | – | ﹤0.01% | 1906 |
|
|
2023
Q3 | $19.8K | Hold |
5,125
| – | – | ﹤0.01% | 1906 |
|
|
2023
Q2 | $30.5K | Buy |
5,125
+1,907
| +59% | +$11.4K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $10.5K | Sell |
3,218
-2,525
| -44% | -$8.26K | ﹤0.01% | 2139 |
|
|
2022
Q4 | $22.7K | Hold |
5,743
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q3 | $34.5K | Hold |
5,743
| – | – | ﹤0.01% | 1714 |
|
|
2022
Q2 | $36.9K | Hold |
5,743
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q1 | $47.4K | Sell |
5,743
-17,543
| -75% | -$145K | ﹤0.01% | 1632 |
|
|
2021
Q4 | $360K | Hold |
23,286
| – | – | ﹤0.01% | 1627 |
|
|
2021
Q3 | $524K | Buy |
23,286
+14,416
| +163% | +$325K | 0.01% | 1429 |
|
|
2021
Q2 | $174K | Buy |
8,870
+7,325
| +474% | +$144K | ﹤0.01% | 2249 |
|
|
2021
Q1 | $51.7K | Buy |
+1,545
| New | +$51.7K | ﹤0.01% | 2534 |
|